Axsome Therapeutics, Inc. (LON:0HKF)

Axsome Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,314	3,275	2,957	2,780	1,052	2,228
Market Cap Growth	10.77%	10.77%	6.36%	164.34%	-52.81%	-22.43%
Enterprise Value	5,217	3,167	2,775	2,669	1,004	2,115
Last Close Price	108.42	67.31	62.30	62.32	28.58	62.25
PS Ratio	10.63	10.63	13.92	66.94	-	-
PB Ratio	71.92	71.92	19.72	30.57	91.10	26.74
P/TBV Ratio	-	-	29.97	84.61	91.10	26.74
EV/Sales Ratio	17.10	10.28	13.06	64.28	-	-
Debt / Equity Ratio	3.38	3.38	0.98	0.86	3.18	0.44
Asset Turnover	0.67	0.67	0.59	0.24	-	-
Inventory Turnover	2.16	2.16	2.68	-	-	-
Quick Ratio	1.99	1.99	3.46	2.47	3.75	7.85
Current Ratio	2.11	2.11	3.63	2.54	3.75	7.85
Return on Equity (ROE)	-231.63%	-231.63%	-159.21%	-298.97%	-201.51%	-70.36%
Return on Assets (ROA)	-27.28%	-27.28%	-24.86%	-52.29%	-56.91%	-30.46%
Return on Capital (ROIC)	-50.30%	-50.30%	-39.31%	-81.33%	-68.00%	-34.16%
Earnings Yield	-4.32%	-7.00%	-6.35%	-5.59%	-9.16%	-3.38%
FCF Yield	-1.93%	-3.14%	-3.87%	-3.50%	-7.62%	-2.58%
Buyback Yield / Dilution	-5.48%	-5.48%	-11.73%	-8.07%	-1.11%	-9.37%
Total Shareholder Return	-5.48%	-5.48%	-11.73%	-8.07%	-1.11%	-9.37%

Source: S&P Capital IQ. Standard template. Financial Sources.